Most people consider psoriasis to be a skin condition, a belief that minimizes the great harm the autoimmune disease can cause. While skin lesions (called plaques) are characteristic of the disease, ...

Nail problems affect nearly 10% of adults, with fungal infections outnumbering psoriasis cases by almost three to one. This prevalence disparity leads many people to automatically assume any nail ...

“Despite affecting an estimated six million Americans, genital psoriasis is often underreported and undertreated due to the uniquely sensitive and private nature of the afflicted ...

Perspective from Anthony P. Fernandez, MD, PhD Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting them at risk for ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...

“This” was guttate psoriasis – a strand of the chronic disease whereby skin cells overproduce, forming scaly, flaky patches – which affects around eight per cent of the roughly 125 million people ...

Results showed 66% of patients treated with icotrokinra achieved an ss-IGA score of 0/1 and 77% achieved a sPGA-G score of 0/1, compared with 11% and 21% receiving placebo, respectively, at week 16.

Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis treated with icotrokinra achieved the study’s primary ...

Skin can get scaly too as ringworm progresses. Psoriasis is an autoimmune disease that leaves a stamp on your skin. It starts as rough, scaly red patches that can become covered by thick ...

Moderate to severe psoriasis describes how much of your body is covered in red, scaly psoriasis patches. Moderate psoriasis covers 3% to 10% of your body. Severe psoriasis covers more than 10% of ...

Psoriasis is a chronic inflammatory disorder for which phosphodiesterase-4 (PDE4) inhibitors have emerged as promising therapeutic agents due to an ability to regulate inflammatory signaling pathways.